The Latest
TestimonyTestimony Before the Kansas Special Committee on Pharmaceutical Studies
Testimony of CCAGW President Tom Schatz on 340B before the Kansas Special Committee on Pharmaceutical Studies
State ActionCCAGW Urges Michigan Representatives to Oppose HB 4878
HB 4878 would change how the federal 340B Drug Discount Program operates in Michigan.
Letters to OfficialsCCAGW Urges Senate to Support Elimination of CMMI
Congress must suspend or eliminate the Center for Medicare and Medicaid Information, which failed to cut costs or improve care.
Letters to OfficialsCCAGW Urges House of Representatives to Support Elimination of CMMI
Congress must suspend or eliminate the Center for Medicare and Medicaid Information, which failed to cut costs or improve care.
Press ReleaseCCAGW Launches New Initiative to Expose CMMI Failures and Protect Patients
CMMI must be responsible for its lack of transparency, unchecked spending, and failed experimentation with Americans’ healthcare.
Letters to OfficialsCCAGW Joins Coalition Opposing Patent Tax
A patent tax would punish innovation, undermine OB3 gains, deter investment, and harm American competitiveness.
Letters to OfficialsCCAGW Joins Coalition Opposing the Increase in FDIC Deposit Insurance Limits
Raising FDIC insurance limits for business accounts imposes high costs, risks moral hazard, and harms consumers.
Agency CommentsCAGW Submits Comments to HHS and HRSA Regarding 340B Rebate Model Pilot Program
HRSA’s 340B Rebate Model Pilot Program is a positive step in the effort to reform a program that is failing to deliver benefits
Letters to OfficialsCCAGW Joins Coalition Opposing the 340B Patients Act
340B Patients Act would worsen 340B abuses by enriching large hospitals and middlemen at the expense of the patients in need.
Letters to OfficialsCCAGW Joins Coalition Supporting President Trump's Effort to Cut Spending With Further Rescissions
Pocket rescissions are a legal, effective way to cut wasteful spending, limit bureaucracy, and fulfill Trump’s efficiency agenda.
Letters to OfficialsCCAGW Urges Senate HELP Committee Republicans to Oppose MFN Policies and Support 340B Reform
MFN policies harm innovation and raise costs; 340B reforms stop hospitals and pharmacies from profiting at patients' expense.
Letters to OfficialsCCAGW Urges House of Representatives to Oppose 340B Patients Act
Vague 340B rules enable hospitals to exploit the program, profiting off patients and insurers while driving up drug costs.
